Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various compo... Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.52 | -11.3785557987 | 4.57 | 4.73 | 4.04 | 99077 | 4.36926065 | CS |
| 4 | -1.38 | -25.4143646409 | 5.43 | 5.54 | 4.04 | 109629 | 4.67521721 | CS |
| 12 | -1.04 | -20.4322200393 | 5.09 | 6.61 | 3.86 | 137633 | 4.80123672 | CS |
| 26 | -6.12 | -60.1769911504 | 10.17 | 10.17 | 3.68 | 144489 | 6.22574663 | CS |
| 52 | -2.51 | -38.262195122 | 6.56 | 10.25 | 3.68 | 129128 | 6.62136037 | CS |
| 156 | -10.13 | -71.4386459803 | 14.18 | 18.12 | 2.7 | 113059 | 7.65342232 | CS |
| 260 | -14.07 | -77.6490066225 | 18.12 | 28.265 | 2.7 | 140154 | 11.56768032 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
